137 related articles for article (PubMed ID: 12904943)
1. Acetylation of the HIV-1 Tat protein: an in vitro study.
Dormeyer W; Dorr A; Ott M; Schnölzer M
Anal Bioanal Chem; 2003 Aug; 376(7):994-1005. PubMed ID: 12904943
[TBL] [Abstract][Full Text] [Related]
2. Probing lysine acetylation in proteins: strategies, limitations, and pitfalls of in vitro acetyltransferase assays.
Dormeyer W; Ott M; Schnölzer M
Mol Cell Proteomics; 2005 Sep; 4(9):1226-39. PubMed ID: 15933374
[TBL] [Abstract][Full Text] [Related]
3. Analysis of p300 acetyltransferase substrate specificity by MALDI TOF mass spectrometry.
Dormeyer W; Ott M; Schnölzer M
Methods; 2005 Aug; 36(4):376-82. PubMed ID: 16085422
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA.
Deng L; Wang D; de la Fuente C; Wang L; Li H; Lee CG; Donnelly R; Wade JD; Lambert P; Kashanchi F
Virology; 2001 Oct; 289(2):312-26. PubMed ID: 11689053
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 tat transcriptional activity is regulated by acetylation.
Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
[TBL] [Abstract][Full Text] [Related]
7. The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat.
Col E; Caron C; Seigneurin-Berny D; Gracia J; Favier A; Khochbin S
J Biol Chem; 2001 Jul; 276(30):28179-84. PubMed ID: 11384967
[TBL] [Abstract][Full Text] [Related]
8. Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.
Ott M; Dorr A; Hetzer-Egger C; Kaehlcke K; Schnolzer M; Henklein P; Cole P; Zhou MM; Verdin E
Novartis Found Symp; 2004; 259():182-93; discussion 193-6, 223-5. PubMed ID: 15171254
[TBL] [Abstract][Full Text] [Related]
9. Acetylated Tat regulates human immunodeficiency virus type 1 splicing through its interaction with the splicing regulator p32.
Berro R; Kehn K; de la Fuente C; Pumfery A; Adair R; Wade J; Colberg-Poley AM; Hiscott J; Kashanchi F
J Virol; 2006 Apr; 80(7):3189-204. PubMed ID: 16537587
[TBL] [Abstract][Full Text] [Related]
10. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity.
Ott M; Schnölzer M; Garnica J; Fischle W; Emiliani S; Rackwitz HR; Verdin E
Curr Biol; 1999 Dec 16-30; 9(24):1489-92. PubMed ID: 10607594
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain.
Dorr A; Kiermer V; Pedal A; Rackwitz HR; Henklein P; Schubert U; Zhou MM; Verdin E; Ott M
EMBO J; 2002 Jun; 21(11):2715-23. PubMed ID: 12032084
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of a highly acetylated protein using a curved-field reflectron mass spectrometer.
Wang D; Thompson P; Cole PA; Cotter RJ
Proteomics; 2005 Jun; 5(9):2288-96. PubMed ID: 15887180
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain.
Mujtaba S; He Y; Zeng L; Farooq A; Carlson JE; Ott M; Verdin E; Zhou MM
Mol Cell; 2002 Mar; 9(3):575-86. PubMed ID: 11931765
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 transcription: activation mediated by acetylation of Tat.
Nakatani Y
Structure; 2002 Apr; 10(4):443-4. PubMed ID: 11937047
[TBL] [Abstract][Full Text] [Related]
15. Bromodomain: an acetyl-lysine binding domain.
Zeng L; Zhou MM
FEBS Lett; 2002 Feb; 513(1):124-8. PubMed ID: 11911891
[TBL] [Abstract][Full Text] [Related]
16. Reversibly acetylated lysine residues play important roles in the enzymatic activity of Escherichia coli N-hydroxyarylamine O-acetyltransferase.
Zhang QF; Gu J; Gong P; Wang XD; Tu S; Bi LJ; Yu ZN; Zhang ZP; Cui ZQ; Wei HP; Tao SC; Zhang XE; Deng JY
FEBS J; 2013 May; 280(9):1966-79. PubMed ID: 23452042
[TBL] [Abstract][Full Text] [Related]
17. Strategy for determination of in vitro protein acetylation sites by using isotope-labeled acetyl coenzyme A and liquid chromatography-mass spectrometry.
Wu HY; Huang FY; Chang YC; Hsieh MC; Liao PC
Anal Chem; 2008 Aug; 80(16):6178-89. PubMed ID: 18616279
[TBL] [Abstract][Full Text] [Related]
18. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S
Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245
[TBL] [Abstract][Full Text] [Related]
19. Post-translational modifications of Trypanosoma cruzi histone H4.
da Cunha JP; Nakayasu ES; de Almeida IC; Schenkman S
Mol Biochem Parasitol; 2006 Dec; 150(2):268-77. PubMed ID: 17010453
[TBL] [Abstract][Full Text] [Related]
20. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins.
Zhang Q; Zhang K; Zou Y; Perna A; Wang Y
J Am Soc Mass Spectrom; 2007 Sep; 18(9):1569-78. PubMed ID: 17627840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
